"Global Image-Guided Biopsy Market – Industry Trends and Forecast to 2028
Global Image-Guided Biopsy Market, By Technology (X- Ray, Ultrasound, Mammograpy, CT, MRI), Process (Fine Needle, Core Needle, Vacuum- Assisted Biopsy), End-User (Hospitals, Ambulatory Surgery Centers, Clinics, Research and Academic Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Access Full 350 Pages PDF Report @
https://www.databridgemarketresearch.com/reports/global-image-guided-biopsy-market
The image-guided biopsy market is expected to witness market growth at a rate of 5.49% in the forecast period of 2021 to 2028 and is expected to reach USD 3,063.03 million by 2028. Data Bridge Market Research report on image-guided biopsy market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increase in the prevalence of cancer globally is escalating the growth of image-guided biopsy market.
**Segments**
- by Product Type: Biopsy Needles, Biopsy Tables, Localization Wires, Guidance Systems
- by Technology: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Fluoroscopy, Others
- by Application: Breast Biopsy, Lung Biopsy, Prostate Biopsy, Liver Biopsy, Others
- by End-User: Hospitals, Diagnostic Centers, Clinics, Research Institutes
Image-guided biopsy procedures have witnessed significant advancements in recent years owing to the increasing prevalence of cancer cases and the growing demand for minimally invasive diagnostic procedures. The market for image-guided biopsies is segmented based on product type, technology, application, and end-user. Biopsy needles, biopsy tables, localization wires, and guidance systems are some of the key product types within this market segment. These products play a crucial role in ensuring accurate and precise tissue sampling during biopsy procedures. The technology segment includes computed tomography, magnetic resonance imaging, ultrasound, fluoroscopy, and other advanced imaging technologies that help in visualizing and guiding the biopsy process. Different applications for image-guided biopsies include breast biopsy, lung biopsy, prostate biopsy, liver biopsy, and various other types of tissue biopsies. The end-users of image-guided biopsy products and services include hospitals, diagnostic centers, clinics, and research institutes, where these procedures are performed to diagnose and monitor various medical conditions effectively.
**Market Players**
- Becton, Dickinson and Company
- Medtronic
- Hologic, Inc.
- Boston Scientific Corporation
- Leica Biosystems Nussloch GmbH
- Danaher
- Stryker
- Siemens Healthineers
- Canon Medical Systems Corporation
- Koninklijke Philips N.V.
The global image-guided biopsy market is characterized by the presence of several key players who are actively involved in product development, partnerships, mergers, and acquisitions to strengthen their market position. Some of the prominentThe global image-guided biopsy market is highly competitive, with key players such as Becton, Dickinson and Company, Medtronic, Hologic, Inc., Boston Scientific Corporation, Leica Biosystems Nussloch GmbH, Danaher, Stryker, Siemens Healthineers, Canon Medical Systems Corporation, and Koninklijke Philips N.V. leading the way in innovation and market presence. These companies have been focusing on research and development activities to introduce advanced products and technologies in the market. Partnerships and collaborations are also common strategies adopted by players to expand their product portfolios and reach a wider customer base. Mergers and acquisitions have been prominent in the market as companies aim to enhance their technological capabilities and global market reach.
The increasing prevalence of cancer worldwide is a major driver for the growth of the image-guided biopsy market. With the rise in cancer cases across various anatomical sites such as the breast, lung, prostate, and liver, there is a growing need for accurate and precise biopsy procedures for early detection and treatment planning. Image-guided biopsies offer minimally invasive approaches compared to traditional surgical biopsies, leading to reduced patient discomfort, shorter recovery times, and improved diagnostic accuracy. This has propelled the adoption of image-guided biopsy procedures in healthcare facilities globally.
Technological advancements in imaging modalities such as computed tomography, magnetic resonance imaging, ultrasound, and fluoroscopy have significantly improved the guidance and accuracy of biopsy procedures. These technologies enable healthcare professionals to visualize the target tissue in real-time, enhancing the success rates of biopsies and reducing the likelihood of repeat procedures. The integration of artificial intelligence and machine learning algorithms in imaging systems further enhances the precision and efficiency of image-guided biopsies, contributing to the overall market growth.
The application of image-guided biopsies extends beyond cancer diagnosis to include other medical conditions such as infectious diseases, inflammatory disorders, and genetic abnormalities. The versatility of image-guided biopsy procedures enables healthcare providers to**Global Image-Guided Biopsy Market, By Technology (X- Ray, Ultrasound, Mammography, CT, MRI), Process (Fine Needle, Core Needle, Vacuum-Assisted Biopsy), End-User (Hospitals, Ambulatory Surgery Centers, Clinics, Research and Academic Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028**
The global image-guided biopsy market is expected to experience substantial growth in the coming years due to several key factors. The increasing prevalence of cancer worldwide, technological advancements in imaging modalities, and the expanding applications of image-guided biopsies beyond cancer diagnosis are driving the market growth. The market players are actively engaged in research and development activities, partnerships, and mergers to enhance their product portfolios and strengthen their market presence. The competitive landscape of the market is intense, with leading companies focusing on innovation and market expansion strategies.
One of the primary drivers of the image-guided biopsy market is the rising burden of cancer cases globally, necessitating accurate and minimally invasive diagnostic procedures.
Highlights of TOC:
Chapter 1: Market overview
Chapter 2: Global Image-Guided Biopsy Market
Chapter 3: Regional analysis of the Global Image-Guided Biopsy Market industry
Chapter 4: Image-Guided Biopsy Market segmentation based on types and applications
Chapter 5: Revenue analysis based on types and applications
Chapter 6: Market share
Chapter 7: Competitive Landscape
Chapter 8: Drivers, Restraints, Challenges, and Opportunities
Chapter 9: Gross Margin and Price Analysis
Core Objective of Image-Guided Biopsy Market:
Every firm in the Image-Guided Biopsy Market has objectives but this market research report focus on the crucial objectives, so you can analysis about competition, future market, new products, and informative data that can raise your sales volume exponentially.
- Size of the Image-Guided Biopsy Market and growth rate factors.
- Important changes in the future Image-Guided Biopsy Market.
- Top worldwide competitors of the Market.
- Scope and product outlook of Image-Guided Biopsy Market.
- Developing regions with potential growth in the future.
- Tough Challenges and risk faced in Market.
- Global Image-Guided Biopsy top manufacturers profile and sales statistics.
Regional Analysis for Image-Guided Biopsy Market:
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
- Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
- North America (U.S., Canada, and Mexico)
- South America (Brazil, Chile, Argentina, Rest of South America)
- MEA (Saudi Arabia, UAE, South Africa)
Browse Trending Reports:
Cryogenic Safety Valve Market
High Performance Lubricant Market
Field Effect Transistor Market
Beetles Protein Market
Animal Protein Hydrolysate Market
Puncheon Barrel Market
Histology And Cytology Market
Diaper Attachment Sensors Market
Amplitude Electro Optic Modulators Market
Disposable Tea Flask Market
Wireless Radio Frequency Transceivers Market
Lined Lug Cap Market
Automotive Torque Actuator Motor Market
Two Terminal Solar Cell Market
Laparoscopic Electrodes Market
Medicinal Herbs Market
Hydrocracking Market
Anechoic Chamber Market
Solar Panel Recycling Market
Measles Mumps And Rubella Vaccines Market
Bentonite Market
Subscription And Billing Management Market
Indium Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
